The following publications are possibly variants of this publication:
- RareDR: A Drug Repositioning Approach for Rare Diseases Based on Knowledge GraphYuehan Huang, Shuting Jin, Xinyu Yu, Changzhi Jiang, Zhengqiu Yu, Xiangrong Liu, Shaohui Huang. icic 2023: 383-394 [doi]
- Partner-Specific Drug Repositioning Approach Based on Graph Convolutional NetworkXinliang Sun, Bei Wang, Jie Zhang, Min Li 0007. titb, 26(11):5757-5765, 2022. [doi]
- MilGNet: A Multi-instance Learning-based Heterogeneous Graph Network for Drug repositioningYaowen Gu, Si Zheng, Bowen Zhang, Hongyu Kang, Jiao Li 0001. bibm 2022: 430-437 [doi]
- Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM ChallengeZhaoping Xiong, Minji Jeon, Robert J. Allaway, Jaewoo Kang, Donghyeon Park, Jinhyuk Lee, Hwisang Jeon, Miyoung Ko, Hualiang Jiang, Mingyue Zheng, Aik Choon Tan, Xindi Guo, Multi-Targeting Drug DREAM Challenge Community, Kristen K. Dang, Alex Tropsha, Chana Hecht, Tirtha K. Das, Heather A. Carlson, Ruben Abagyan, Justin Guinney, Avner Schlessinger, Ross Cagan. ploscb, 17(9), 2021. [doi]
- Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based InferenceFeixiong Cheng, Chuang Liu, Jing Jiang, Weiqiang Lu, Weihua Li, Guixia Liu, Wei-Xing Zhou, Jin Huang, Yun Tang. ploscb, 8(5), 2012. [doi]